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INTRODUCTION 
Humankind has entered a new era. In November, 2005, the U.S. Centers for Disease Control and Prevention 
counted 50 emerging and re-emerging communicable diseases, as listed in Table 1.1 Certainly these, and other 
equally formidable, threats to individual and global health will require new approaches for the 21st Century. 
Indeed, as part of rapidly evolving public health reform in the United States, the Association of Schools of Public 
Health has identified 12 core competencies by those who seek the Master of Public Health (MPH) degree.2 These 
core competencies include five discipline-specific competency lists in: Biostatistics, Environmental Health Sciences, 
Epidemiology, Health Policy and Management, and Social and Behavioral Sciences. The core competencies also 
include a list of interdisciplinary/cross-cutting competencies across seven overarching domains in: Communication 
and Informatics, Diversity and Culture, Leadership, Professionalism, Program Planning, Public Health Biology, and 
Systems Thinking. 
Systems Thinking. 
To be brief, our traditional means of managing a given public health threat generally have focused more on 
separating, analyzing, and addressing individual components of the threat (including components of the health threat 
and strategies to resolve it). In contrast, systems approaches to managing a given public health threat generally focus 
on: critical inter-relationships among components of the health threat, other health threats, and strategies to address 
the given health threat and related threats. Leischow and Milstein3 explain that: 
... there is no single discipline for systems thinking, precisely because it is oriented to the linkage of disciplines. Equally important is an emphasis on 
relating different types of structures that shape our lives, including the biological systems of our bodies, the \[public health and other\] organizational 
systems in which we work, and the political systems with which we govern public affairs. Although there is no simple operational method for identifying 
and interpreting these relationships, there is, in fact, a common conceptual orientation recognizable as a systems approach: it is a paradigm or perspective 
that considers connections among different components, plans for the implications of their interaction, and requires transdisciplinary thinking as well as 
active engagement of those who have a stake in the outcome to govern the course of change. 
Genetic, Non-Communicable, Environmental, & Communicable Health Threats 
Illustrative of systems thinking, although it proves helpful to categorize health threats, we usefully are beginning 
to understand critical relationships among such categories.4 Illustratively, we have learned that genetic factors, in 
addition to contributing to genetic diseases, also can determine significant susceptibility or significant resistance to 
non-communicable, environmental, and communicable health threats. Further, although classified as a non-
communicable disease, asthma can be caused or exacerbated either by infectious agents, by environmental 
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contaminants in the air, or by both. We recently have learned several diseases previously thought to be non-
communicable have been linked to infectious agents: peptic ulcer disease with Heliobacter pylori, cervical cancer 
with several human papillomaviruses, liver cancer and cirrhosis with hepatitis B and C viruses, to name a few. 
Evidence also is accumulating that microorganisms might cause or exacerbate atherosclerosis and cardiovascular 
disease, type 1 diabetes, inflammatory bowel disease, neurological diseases and neuropsychiatric disorders, and 
developmental problems among children. Environmental geographic agents (arsenic, iodine insufficiency) 
agricultural agents (pig, chicken, duck, and cattle production; herbicides and pesticides), and industrial agents (PCB, 
dioxin), might precipitate or aggravate diseases such as various cancers, goiter, mental retardation, Rift Valley Fever, 
bovine spongiform encephalopathy, pfiesteria, severe acute respiratory syndrome (SARS), H5N1 (Avian) influenza, 
neurological and developmental disorders, and compromised immunity. 
Simultaneous Global Threats to the Public’s Health in the 21st Century 
As we enter the 21st Century, humankind faces at least the following 16 discrete, yet inter-related, global threats 
to the public’s health. Addressing one or two of these threats alone will require resources and collaboration 
heretofore unknown in the history of our species. Addressing all 16 simultaneously will require new strategies; and, 
more important, a new global ethic. These global threats include: (1) populations increasing, urbanizing, poor, 
famined, and migrating; (2) increasingly toxic environments, deforestation, and insufficient or undrinkable water; (3) 
global air pollution, warming, dimming, climate changes, storms, floods, and droughts; (4) emerging and re-
emerging diseases and global pandemics; (5) antimicrobial resistance; (6) rapid as well as slower transportation 
available to masses of people; (7) chronic diseases from environments and behavioral patterns; (8) unintentional and 
intentional physical and psychological injuries; (9) conventional, biological, chemical and radiological terrorism; 
(10) war undeclared, declared, intra-national, international, and nuclear; (11) natural disasters, including earthquakes, 
tsunamis, volcanoes, possible asteroids; (12) demographic extremes, aging and adolescent populations; (13) rapid 
changes in cultures; (14) stress, anxiety, depression, dementia, and consequently suppressed immune systems; (15) 
increasing economic globalization and economic disparities; and (16) increasing health disparities, underserved, and 
uninsured populations. 
Public Health Reform 
Public health workers, academicians, and leaders rapidly are applying systems thinking to reform our very 
conceptualization, organization, training, practice, and evaluation of efforts to protect and improve the public’s 
health. In 1988, the Institute of Medicine Committee redefined public health as “what we as a society do collectively 
to assure the conditions in which people can be healthy.”5 In 2003, the Institute of Medicine Committee on The 
Future of the Public’s Health in the 21st Century articulated the reasons for, and the nature of, public health reform 
as follows.6
Health is a primary public good because many aspects of human potential... are contingent on it. In view of the value of health to employers, business, 
communities, and society in general, creating the conditions for people to be healthy should... be a shared social goal... The special role of government 
must be allied with the contributions of other sectors of society. The emphasis on an intersectoral public health system does not supersede the special duties 
of the governmental public health agencies, but, rather, complements it with a call for the contributions of other sectors of society that have enormous 
power to influence health...  
 A public health system would include the governmental public health agencies, the health care delivery system, and the public health and health 
sciences academia, sectors that are heavily engaged and more clearly identified with health activities...\[But it also would include\] communities and their 
many entities (e.g. schools, organizations, and religious congregations), businesses and employers, and the media as potential actors in the public health 
system... 
Such a public health system would comprise “...a complex network of individuals and organizations that, when 
working together, can represent ‘what we as a society do collectively to assure the conditions in which people can be 
healthy.’”6 A graphic depiction of A Public Health System for the 21st Century is represented by Chart 1.7 Such a 
system increasingly will require collaboration and integration of efforts across public-sector, not-for-profit \[or civil\] 
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sector, and private-sector agencies. Importantly, it also will require substantially increasing collaboration among 
nations to improve the public’s health in any one nation and among all nations. 
Training Public Health Workers 
Training not only health department workers, but workers in all other agencies of the public health system 
Training not only about previous local health threats, but about global health threats in the 21st Century 
Training not only about independent health threats and independent agency responses, but about simultaneous 
(syndemic) health threats and public health system responses 
Health Literacy: Educating the Public and Decision-Makers 
A New Ethic for a New Era 
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Table 1 
Emerging and Re-Emerging Communicable Diseasesd 
1. rug-resistant infections (antimicrobial resistance) 
2. bovine spongiform encephalopathy (Mad cow disease) and variant Creutzfeldt-Jakob disease (vCJD)  
3. campylobacteriosis 
4. Chagas disease 
5. cholera 
6. cryptococcosis 
7. cryptosporidiosis (Crypto) 
8. cyclosporiasis 
9. cysticercosis 
10. dengue fever 
11. diphtheria 
12. Ebola hemorrhagic fever 
13. Escherichia coli infection 
14. group B streptococcal infection 
15. hantavirus pulmonary syndrome 
16. hepatitis C 
17. hendra virus infection 
18. histoplasmosis 
19. HIV/AIDS 
20. influenza 
21. Lassa fever 
22. legionnaires’ disease (legionellosis) and Pontiac fever 
23. leptospirosis 
24. Listeriosis 
25. Lyme disease 
26. malaria 
27. Marburg hemorrhagic fever 
28. measles 
29. meningitis 
30. monkeypox 
31. MRSA (Methicillin Resistant Staphylococcus aureus) 
32. Nipah virus infection 
33. norovirus (formerly Norwalk virus) infection 
34. pertussis 
35. plague 
36. polio (poliomyelitis) 
37. rabies 
38. Rift Valley fever 
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39. rotavirus infection 
40. salmonellosis 
41. SARS (Severe acute respiratory syndrome) 
42. shigellosis 
43. smallpox 
44. sleeping Sickness (Trypanosomiasis) 
45. tuberculosis 
46. tularemia 
47. valley fever (coccidioidomycosis) 
48. VISA/VRSA-Vancomycin-Intermediate/Resistant Staphylococcus aureus 
49. West Nile virus infection 
50. yellow fever 
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A large body of epidemiological evidence suggests an association between ambient air pollution and 
cardiovascular mortality and morbidity, but the majority of these studies have been conducted in the developed 
Western world. The major risks have been linked to SO2 and PM. Sulfur dioxide is associated with increased daily 
mortality from both respiratory and cardiovascular disease even at the low levels now observed in the Western 
hemisphere. 
 Large cohort studies, using the same protocol, have been conducted in Western Europe based upon 29 cities 
(APHEA; Katsouyanni et al, 2001) and the US based upon 90 cities (NMMAPS; Samet et al, 2000), while a small 
number of studies have been conducted in Asia. The estimates of percent change per 10 ug/m3 increase in pollutant 
concentration on all-cause mortality showed slight variation, ranging form 0.41 in Asia and US to 0.6 in Europe for 
PM10, whereas it was 0.35 for Asia and 0.40 in Europe for SO2. PM2.5 appears to be more closely associated with 
mortality than PM10 or total suspended particulate matters (TSP). However, most of these studies have been 
conducted in the US (Pope et al, 2002). There are some concern using these data for estimation of risk in other 
populations due to difference in methods collecting and analyzing the concentrations of the particle and the chemical 
composition, e.g. different sources, different ratio between fine and coarse particles. 
Long term exposure to ambient PM contributes to systemic inflammatory pathways, which are relevant aspects of 
atherogenesis resulting in atherosclerosis and ultimately cardiovascular death. Carotid artery intima-media thickness 
(CIMT) is normally considered a risk indicator of atherosclerosis. A recent epidemiological study has shown an 
association between PM2.5 and CIMT, and indirectly the risk of atherosclerosis. The risk was higher in women with 
a 15% increase in CIMT for a 10 ug/m3 increase in PM2.5 (K nzli et al, 2005).  
Increased risk for infant and child mortality from respiratory diseases has been associated with exposure to air 
pollution both in developed and developing countries (Romieu et al, 2002). 
Respiratory disorders 
Exposure to traffic related air pollution has been implicated in impairment of respiratory health in children. Truck 
traffic and air pollutants associated with truck traffic were associated with chronic respiratory symptoms in Dutch 
school children living close to motorways, whereas there was no association with car traffic. Furthermore, there was 
no association with bronchial hyperresponsiveness in these children, however sensitization to outdoor allergen was 
increased in the group exposed to high level of air pollution (Janssen et al, 2003). The increased sensitivity to 
outdoor allergen may be a consequence of the fact that diesel exhaust particles modifies the allergen and enhances 
the immunologic response of the allergen and increase the inflammatory responses as demonstrated both in animal 
studies and human volunteer studies (Diaz-Sanchez et al, 2000). 
Air pollution has not been found to induce asthmatic conditions in children, but will exuberate an already existing 
condition.  
Cancer 
Epidemiological studies have indicated that in Western countries the relative risk of developing lung cancer is 1.5-
fold higher in urban that in rural areas after adjusting for cigarette smoking. Air pollution, e.g. vehicles, industry, 
power plants, has been reported to increase the risk of lung cancer (Vinies et al, 2004). The risk of lung cancer death 
has been suggested to increase by 8% for every 10 micrograms of fine particles/m3 of inhaled air (Nafstad et al, 
2003). Epidemiological studies have also shown strong support for that the higher risk of lung cancer among non-
smoking women in Xuanwei County, China is associated with the use of smoky coal for cooking and heating in 
homes without chimneys. The smoke of smoky coals is high in carcinogenic PAH (Keohavong et al, 2005). 
Exposure assessment 
Numerous epidemiological studies have reported association between outdoor concentrations of air pollutants 
and adverse health effects. Most studies have been using ambient monitoring data to estimate exposure. However, in 
case of PM, personal exposure is dominated by indoor sources especially taking into consideration that people spent 
up to 90% of their time indoor, thus the validity of using ambient concentrations as an exposure estimate may 
introduce misclassification. The risk of misclassification is less for gaseous air pollutants except in cases where a 
significant in-door source is present, e.g. nitrogen oxides. An alternative to ambient and personal measurement is the 
use of biomarkers to assess exposure, and a further advantage of these biomarkers is that they also reflect the time-
activity pattern. 
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The ultimate biomarker represents both an accurate exposure estimate and is also an indicator of health. Several 
biomarkers have been developed to assess exposure for genotoxic compounds in ambient air. Some of these 
biomarkers represent the exposure for specific compounds, e.g. benzene in blood and urine, and its metabolites, 
muconic acid and phenylmercapturic acid, in urine. However, the level of these products is not linked to the 
genotoxic effect. 1-hydroxypyrene (1-HOP) is another commonly used biomarker for PAH exposure although 
pyrene is not specific for ambient air pollution and can also be found in food. The carcinogenic PAH found to be 
associated with particles are metabolized to reactive molecules that can react with DNA to form bulky-DNA 
adducts. DNA adducts tend to be higher among subjects heavily exposed to urban and occupational pollutants 
(Autrup et al, 1999; Peluso et al, 2001). PAH-DNA adducts have also been detected in the blood from newborns, 
whose mothers were living in polluted areas of Poland and China. The adduct level was similar in mothers and in 
the child (Perera et al, 2005) suggesting that carcinogenic agents present in ambient can pass the placental barrier 
and initate damage in the unborn child that is relevant for carcinogenesis. A positive association has been 
established between the level of PAH in ambient air and the bulky adduct level at medium to high level of PAH, but 
not at the low level situation generally observed at ambient pollution. A weak but positive association has been 
established between the bulky adduct level and risk of development of lung cancer (Peluso et al, 2005; Bak et al, 
2005) Particles generated by combustion are composed of a carbon core to which other compounds such as metals 
and PAH adhere. The particles do induce oxidative stress mediated by a particle-induced inflammation causing 
macrophages to release ROS. Oxidative stress to DNA is frequently measured as 8-oxodG. In a study among human 
volunteers we found a positive association between individual PM exposure and 8-oxodG, whereas no association 
was found between amount of PM and bulky adducts (S rensen et al, 2003). One of the consequences of DNA 
adducts, when un-repaired, is the induction of mutations that may ultimately induce cancer formation. An increased 
frequency of mutations in the p53 cancer suppressor genes has been observed both in the sputum of individuals 
exposed to smoky coal emission and in lung tumors from people in the region. The most frequently observed 
mutation seen in this group is a G to T transversion that is commonly associated with exposure to carcinogenic PAH 
(Keohavong et al, 2005). 
Susceptible populations 
Increased risk for adverse health effects due to air pollution could be related either to higher dose, acquired 
predisposing diseases and genetic susceptibility. 
In the group exposed to higher dose are people living or working along highly trafficked roads, people with long 
commuting hours, or people who are occupationally exposed, e.g. bus drivers, traffic police officers. This group 
does also include children as their body burden with air pollutants is higher than adduct due to a relative high 
ventilation rate. 
Elderly subjects, and especially subjects with pre-existing heart and lung disease are more susceptible to the 
effect of short-term ambient air pollution on mortality and morbidity. Asthmatics do also respond stronger than non-
asthmatic on increase in air pollution, particularly PM. In case of long-term exposure, socially disadvantaged and 
poorly educated populations respond more strongly in term of mortality.  
The toxic effects of air pollutants are modified by genetic variation in genes involved in, e.g. inflammatory 
processes, defense against reactive oxygen species formed by particulate matters, enzymes involved in the 
detoxification of PAH and other toxic compounds present in ambient air. 
Prevention
Improving air quality will improve the quality of life and have important impact on economic development. 
Mobile sources are the major contributor to ambient air pollution in developed countries. Thus, stringent standards 
for new sources of air pollution (especially motor vehicles) will significantly improve air quality. However, the 
increasing economic welfare will result in an increasing number of vehicles and longer commuting distances, so the 
net benefits of these standards may be negligible. As the level of the pollution depends on the engine type and 
condition, fuel type, traffic congestions, driving habits and load of vehicles stricter control and introduction of 
cleaner technologies, e.g. hybrid cars. Furthermore, improved city planning to minimize traffic congestions and 
development of public transportation may help in minimize the air pollution in the megacities and improve the 
quality of life. 
Biomarkers 
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